1.Diagnose and treatment of post-cesarean section scar diverticulum by hysteroscopy combined ultrasonography and laparoscopy
Jing YUAN ; Hua DUAN ; Yinshu GUO ; Jinjuan WANG ; Jiumei CHENG ; Hong YE
Chinese Journal of Obstetrics and Gynecology 2015;(4):274-277
Objective To investigate the application of hysteroscopy combined ultrasonography and laparoscopy in the diagnose and treatment of post-cesarean section scar diverticulum (PCSD). Methods From March 2011 to February 2013, 27 patients with PCSD were diagnosed and treated in Beijing Obstetrics and Gynecology Hospital. All patients were diagnosed by hysteroscopy and ultrasonography. Treatment protocols were decided by the thickness of the diverticulum. The clinical data of all patients were analysed fully. Results (1)All patients were diagnosed by hysteroscopy combined ultrasound, of which only 17 cases were diagnosed by preoperative ultrasound, the coincidence rate was 63%(17/27). (2)The thickness of diverticulum was measured by hysteroscopy combined ultrasound. Thickness of less than 3 mm in 19 cases, were treated by hysteroscopy combined with laparoscopy diverticulectomy repair;no less than 3 mm in 8 cases, were used hysteroscopy diverticulum incision. (3)The effective rate was 7/8 after hysteroscopy, and which was 16/19 after laparoscopy combined with hysteroscopy surgery. There was no difference in the treatment effect (P=0.663). The ineffective rate was 1/8 after hysteroscopy, and which was 3/19 after laparoscopy combined with hysteroscopy surgery. The size of the PCSD was smaller and the thickness of diverticulum was thicker than preoperation in the later one, which has no difference in the former one. Conclusions (1)Hysteroscopy combined ultrasound is an accurate method for the diagnose of PCSD. (2)According to the thickness of the diverticulum operation method is choosed, which is beneficial to reduce the trauma, and relieve symptoms. (3)Diverticulum poor positioning and incomplete resection are the main causes of postoperative recurrence of the diverticulum.
2.Analysis of Unreasonable Dug Use in One Case of Type 2 Diabetes with Complicated Urinary Tract Infec-tion
Jinjuan GUO ; Zengxian SUN ; Li JING
China Pharmacist 2017;20(10):1828-1830
Objective:To analyze one case of unreasonable drug use to promote reasonable drug use in clinics. Methods: The treatment regimen with irrational drug use for one case of type 2 diabetes with complicated urinary tract infection were analyzed, and the reasons for the irrationality were summarized and some suggestions for avoiding unreasonable drug use were put forward. Results:The choice of moxifloxacin in the initial treatment was irrational, and no combination indications were shown. Clinical pharmacists partici-pated in the ward rounds and timely communicated with the clinicians to correct the drug use. Conclusion:Due to the drug resistance, pharmacokinetic characteristics and adverse reactions, moxifloxacin is unsuitable for the anti-infection treatment of complicated urinary tract infection. Clinical pharmacists should provide individualized treatment for patients to improve the effectiveness of drug therapy.
3.Analysis of Unreasonable Dug Use in One Case of Type 2 Diabetes with Complicated Urinary Tract Infec-tion
Jinjuan GUO ; Zengxian SUN ; Li JING
China Pharmacist 2017;20(10):1828-1830
Objective:To analyze one case of unreasonable drug use to promote reasonable drug use in clinics. Methods: The treatment regimen with irrational drug use for one case of type 2 diabetes with complicated urinary tract infection were analyzed, and the reasons for the irrationality were summarized and some suggestions for avoiding unreasonable drug use were put forward. Results:The choice of moxifloxacin in the initial treatment was irrational, and no combination indications were shown. Clinical pharmacists partici-pated in the ward rounds and timely communicated with the clinicians to correct the drug use. Conclusion:Due to the drug resistance, pharmacokinetic characteristics and adverse reactions, moxifloxacin is unsuitable for the anti-infection treatment of complicated urinary tract infection. Clinical pharmacists should provide individualized treatment for patients to improve the effectiveness of drug therapy.